The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $1.98

Today's change-0.04 -1.98%
Updated May 25 3:32 PM -4GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $1.98

Today's change-0.04 -1.98%
Updated May 25 3:32 PM -4GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc down (U.S.)$0.04

Repros Therapeutics Inc is sharply lower today, dropping (U.S.)$0.04 or 1.98% to (U.S.)$1.98. Shares have lost 7.91% over the last five days, but have gained 63.64% over the last year to date. This security has underperformed the S&P 500 by 72.65% during the last year.

Key company metrics

  • Open(U.S.) $1.91
  • Previous close(U.S.) $2.02
  • High(U.S.) $2.05
  • Low(U.S.) $1.88
  • Bid / Ask(U.S.) $1.98 / (U.S.) $1.99
  • YTD % change+63.64%
  • Volume432,684
  • Average volume (10-day)706,147
  • Average volume (1-month)5,350,296
  • Average volume (3-month)1,888,048
  • 52-week range(U.S.) $0.80 to (U.S.) $8.96
  • Beta-0.22
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.05
Updated May 25 3:32 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5678
Selling / general / administrative2523
Research & development3155
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-6-7-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-6-7-8
Income after tax-5-6-7-8
Income tax, total--------
Net income-5-6-7-8
Total adjustments to net income--------
Net income before extra. items-5-6-7-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-6-7-8
Inc. avail. to common incl. extra. items-5-6-7-8
Diluted net income-5-6-7-8
Dilution adjustment------0
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.20-0.26-0.27-0.32
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.20-0.26-0.27-0.32